Agilux Laboratories Adds In Vivo PK/PD Services

Share Article

Agilux Laboratories expands its service offering to include In Vivo PK/PD servcies to be led by Sean Maki.

“Sean and the experienced team he has assembled bring the expertise and knowledge necessary to consistently deliver timely, quality PK/PD services to our discovery clients” stated Steve Guyan, VP of Sales and Marketing.

Agilux Laboratories, Inc., a Contract Research Organization (CRO) that provides Discovery Bioanalytical, In Vitro ADMET and GLP bioanalytical services to the pharmaceutical and biotech industries has appointed Sean Maki as Associate Director of its newly launched In-Vivo PK/PD Services division. Sean brings to Agilux more than 15 years of “hands on” experience in all aspects of in-vivo services and operations and will be responsible for the overall growth and management of the division, extending Agilux’s emphasis on customer service, rapid turnaround and exceptional data quality.

“We are very pleased and excited to have someone of Sean’s experience and demonstrated abilities to lead our In-Vivo Services Division”, said Jim Jersey, president & CEO of Agilux Laboratories. “With the opening of the vivarium in our Worcester facility, we are particularly excited about offering our discovery clients an increasingly more integrated, bundled service offering. With single points of contact, reduced transactional overhead and the speed advantage of fully integrated bioanalytical support, this offering is consistent with our goal of dose to final data in 3 days; Better Data Faster”.

“Sean and the experienced team he has assembled bring the expertise and knowledge necessary to consistently deliver timely, quality PK/PD services to our discovery clients” stated Steve Guyan, VP of Sales and Marketing. We have worked with Sean and his team before and this enables the rapid integration of this service into our other offerings”.

“Agilux has an established reputation for quality and speed and I am excited by the opportunity to expand that reputation to include in-vivo PK/PD services” said Sean Maki, Associate Director, In Vivo PK/PD Services.

Founded in 2007, Agilux has become the largest bioanalytical contract laboratory in New England by focusing on high quality, rapid turnaround services for discovery support. The company intends to apply the same customer-focused approach in its expansion into In Vivo PK/PD services.

About Agilux Laboratories Inc.

Agilux Laboratories Inc. is a privately held Contract Research Organization (CRO) focused upon providing discovery bioanalytical and In-Vitro ADMET and regulatory compliant GLP bioanalytical services to the pharmaceutical and biotech industries. Leveraging the prior industry and CRO experience of its management team, combined with the “green field” advantages of a fresh start, Agilux seeks to provide its clients better data faster. Founded in 2007 by industry veterans Jim Jersey, Steve Guyan and Peter Glick, Agilux is headquartered in Worcester, MA is funded by private equity firm Ampersand Ventures. For more information call 508 753 5000 or email sguyan(at)agiluxlabs(dot)com. Online at http://www.agiluxlabs.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Steve Guyan
Visit website